Skip to main content
Dr. Kiersten Stead

Dr. Kiersten Stead

Unclaimed
Managing Partner, DCVC Bio, DCVCDCVCSan Francisco, CA

Current Firm

DCVC

Investments

12+ companies

Focus

Deeptech, Biotech

Focus Areas

Investment Stage

Pre-Seed
Seed
Series A
Series B+

Notable Investments

Investment Profile

Dr. Kiersten Stead is a Managing Partner, DCVC Bio, DCVC at DCVC, based in San Francisco, CA.

Dr.'s investment focus spans Deeptech, Biotech, Climate, Digital Health, primarily investing at the Seed, Series A stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.

Notable investments in Dr.'s portfolio include Zoom. These companies reflect a pattern of backing high-potential startups across their focus sectors.

Frequently Asked Questions

Who is Dr. Kiersten Stead?

Dr. Kiersten Stead is a Managing Partner, DCVC Bio, DCVC at DCVC, based in San Francisco, CA. Their investment focus includes Deeptech, Biotech, Climate.

What does Dr. Kiersten Stead invest in?

Dr. Kiersten Stead focuses on investments in Deeptech, Biotech, Climate, Digital Health through DCVC. These focus areas reflect their domain expertise and the types of startups they actively seek to back.

What are Dr. Kiersten Stead's most notable investments?

Dr. Kiersten Stead's notable portfolio investments include Dr. John Hamer, Checkr, Ginkgo Bioworks, SingleStore, CircleCI. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.

What firm is Dr. Kiersten Stead at?

Dr. Kiersten Stead is currently at DCVC, headquartered in San Francisco, CA, serving as Managing Partner, DCVC Bio, DCVC.

Fund Operations Resources

Independent guides to the software and workflows venture investors and their firms use to run funds.

Related tools and reading

Sponsored
AArchstone

The operating system for private capital.

Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.

LP portalCapital calls$297/moNo AUM fees
Book a demo